glp-1
Prescription Weight Loss: Medicare's $320 B Debt Explosion
Medicare could spend an extra $320 billion on GLP-1 weight-loss drugs between 2025 and 2035, a ten percent rise in federal outlays. The estimate comes from recent forecasting models that track the surge in GLP-1 prescriptions across the United States. Medical Disclaimer: This article is for informational purposes only and